The document discusses stability testing of drug substances and products. Stability testing aims to provide evidence of how a drug's quality changes over time under various environmental factors like temperature, humidity and light. It helps establish a re-test period or shelf life for the drug and recommended storage conditions. Key aspects covered include selection of batches, testing frequency and storage conditions for long-term, intermediate and accelerated stability studies as per ICH Q1A guidelines. Specifications include attributes tested and acceptance criteria.
This document provides information on process validation for ampoules and vials. It discusses the key steps in prospective, concurrent, and retrospective validation including pre-validation requirements. Critical process parameters for vial washing, depyrogenation, filling, sealing, and other sterile processing steps are identified. Process validation aims to demonstrate the manufacturing process will consistently produce sterile products meeting specifications. Quality control checks like leak testing, pyrogen testing, sterility testing, and particulate evaluation are summarized.
This presentation covers the manufacture and testing of all sterile drug products, including drugs that are sterilized by filtration or other means and aseptically processed, and drug products that are terminally sterilized. The type of products covered include sterile bulk drugs, ophthalmic drugs, otic dosage forms, small volume parenteral (SVS) products for small molecule and licensed biological
therapeutic drug products, large volume parenteral (LVP) products, and any other drug products required to be sterile or labeled as sterile. Center for Biologics Evaluation and Research (CBER) regulated products and veterinary drug products are excluded from coverage under this program.
The guidance information is tailored to sterile manufacturing operations and should be used in conjunction with the Compliance Program for Drug Manufacturing Inspections (CP 7356.002).
The document discusses cleaning validation, including definitions, purposes, mechanisms, agents, methods, parameters, groupings, worst case considerations, acceptance criteria, and more. Cleaning validation is defined as the process of removing contaminants from equipment and monitoring such that equipment can be safely reused. It aims to ensure product integrity, prevent cross contamination, and meet regulatory requirements.
This document provides information about qualification of an autoclave. It defines qualification as proving that equipment works correctly and leads to expected results. It discusses different types of qualification including design, installation, operational, and performance qualification. For autoclave qualification, it outlines tests that should be performed at each stage like temperature mapping, alarm checks, steam penetration tests, and biological indicator testing to prove the autoclave is sterilizing properly. It also provides guidelines for safe operation of the autoclave.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
This document summarizes the validation process for dry powder mixers used in pharmaceutical manufacturing. It discusses the need to validate mixers to ensure proper blending of active and inactive ingredients. The validation process includes installation qualification, operational qualification, and performance qualification to test the mixer under different conditions. Key parameters tested include content uniformity, bulk density, and sieve analysis of samples taken from different locations within the mixer. Advanced analytical tools can also be used to monitor blending in real time.
The document discusses stability testing of drug substances and products. Stability testing aims to provide evidence of how a drug's quality changes over time under various environmental factors like temperature, humidity and light. It helps establish a re-test period or shelf life for the drug and recommended storage conditions. Key aspects covered include selection of batches, testing frequency and storage conditions for long-term, intermediate and accelerated stability studies as per ICH Q1A guidelines. Specifications include attributes tested and acceptance criteria.
This document provides information on process validation for ampoules and vials. It discusses the key steps in prospective, concurrent, and retrospective validation including pre-validation requirements. Critical process parameters for vial washing, depyrogenation, filling, sealing, and other sterile processing steps are identified. Process validation aims to demonstrate the manufacturing process will consistently produce sterile products meeting specifications. Quality control checks like leak testing, pyrogen testing, sterility testing, and particulate evaluation are summarized.
This presentation covers the manufacture and testing of all sterile drug products, including drugs that are sterilized by filtration or other means and aseptically processed, and drug products that are terminally sterilized. The type of products covered include sterile bulk drugs, ophthalmic drugs, otic dosage forms, small volume parenteral (SVS) products for small molecule and licensed biological
therapeutic drug products, large volume parenteral (LVP) products, and any other drug products required to be sterile or labeled as sterile. Center for Biologics Evaluation and Research (CBER) regulated products and veterinary drug products are excluded from coverage under this program.
The guidance information is tailored to sterile manufacturing operations and should be used in conjunction with the Compliance Program for Drug Manufacturing Inspections (CP 7356.002).
The document discusses cleaning validation, including definitions, purposes, mechanisms, agents, methods, parameters, groupings, worst case considerations, acceptance criteria, and more. Cleaning validation is defined as the process of removing contaminants from equipment and monitoring such that equipment can be safely reused. It aims to ensure product integrity, prevent cross contamination, and meet regulatory requirements.
This document provides information about qualification of an autoclave. It defines qualification as proving that equipment works correctly and leads to expected results. It discusses different types of qualification including design, installation, operational, and performance qualification. For autoclave qualification, it outlines tests that should be performed at each stage like temperature mapping, alarm checks, steam penetration tests, and biological indicator testing to prove the autoclave is sterilizing properly. It also provides guidelines for safe operation of the autoclave.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
This document summarizes the validation process for dry powder mixers used in pharmaceutical manufacturing. It discusses the need to validate mixers to ensure proper blending of active and inactive ingredients. The validation process includes installation qualification, operational qualification, and performance qualification to test the mixer under different conditions. Key parameters tested include content uniformity, bulk density, and sieve analysis of samples taken from different locations within the mixer. Advanced analytical tools can also be used to monitor blending in real time.
The document provides information about auditing a microbiological laboratory. It defines quality audits and outlines the scope and objectives of auditing. Key areas that are audited include laboratory equipment, standard operating procedures, documentation, environmental monitoring, and testing processes. The document discusses auditing the laboratory facility, equipment, documentation systems, and testing methods to ensure compliance with standards.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
The two most commonly used within microbiology are
HACCP (which originated in the food industry) and FMEA
(developed for engineering). This article explores these two
approaches, first with a description of HACCP, followed by a
description and case study of FMEA in sterility testing.
This document discusses key considerations for the aseptic manufacturing of sterile pharmaceutical products. It covers classification of clean areas, environmental monitoring, preparation and filtration of solutions, personnel requirements, equipment sterilization, and validation of aseptic processes. The main objectives are to prevent microbial contamination and maintain sterility throughout manufacturing.
Good Manufacturing PracticeFor LVP,SVP, ophthalmic veterinary medicine, bulk chemicals & invitro diagnostic
For Good business Practice
A control process gives reproducibility & product consistency with in known limits
Provides license to do business.
Stability study of Pharmaceutical Products and Regulatory Requirements Md. Zakaria Faruki
A marketed product stability program fulfills registration
commitments and ensures that marketed product is
stable until expiry date stamped on product
label....
Stability studies should be planned on the
basis of pharmaceutical R&D and regulatory
requirements...
This document summarizes guidelines for stability testing of biotechnological and biological products. It discusses factors that can affect stability, including temperature, humidity, light and container materials. The guidelines specify conducting real-time stability studies at the proposed storage temperature and testing potency, purity and degradation over time. Manufacturers must propose a stability-indicating profile and validate methods to detect any changes to the identity, purity or potency of the product.
Self-inspection and quality audits are important parts of a quality management system to ensure ongoing compliance with good manufacturing practices (GMP). Self-inspections evaluate all aspects of production and quality control to detect any noncompliance and recommend corrective actions. The self-inspection team should consist of objective personnel not from the departments being inspected. The inspection covers facilities, equipment, documentation, hygiene, and other GMP requirements. Quality audits supplement self-inspections by examining the entire quality system. Supplier audits also help ensure materials meet specifications. GMP inspectors evaluate a company's self-inspection program through reviewing records and policies to check that inspections are properly conducted and documented.
This document provides an overview of cleaning validation. It defines cleaning validation as removing contaminants from equipment to safely reuse. It discusses cleaning mechanisms like solubility and wetting. Common cleaning agents include water, surfactants, solvents, acids, bases and oxidants. Automated cleaning methods are fixed CIP while manual includes soaking, brushing and wiping. Key cleaning parameters are time, temperature, chemistry and flow. The document also covers grouping strategies to select representative items for validation and considering worst cases.
The document outlines procedures for investigating out-of-specification or atypical laboratory test results. It describes conducting a Phase I investigation by the analyst and supervisor to identify obvious errors, and a Phase II investigation when no error is found. Phase II may involve hypothesis testing, retesting using the original sample if possible, or obtaining a new sample. If no assignable cause is identified after manufacturing and laboratory investigations, retesting a portion of the original sample may be considered with approval of a documented test plan.
Change control is a formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might effect a validated status. The intent is to determine the need for the action that would ensure that the system is maintained in a validated state.
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
These are the tests performed between QA and QC and provides for the authorization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC such as physical, chemical, microbiologic and biologic tests.
The document summarizes ICH guidelines for stability studies of new drug substances and products. It discusses the objectives and scope of stability testing, including providing evidence of a drug's quality over time under various environmental conditions to establish storage requirements and shelf life. The types of stability testing include chemical, physical, microbiological, therapeutic, and toxicological. Testing is conducted over various time periods and storage conditions as outlined in the ICH Q1A-Q1F guidelines. Evaluation of stability data includes assessing parameter results and using statistical analyses to determine a product's retest period or shelf life.
paharmaceutical packaging Medical device Packaging types of medical device p...RavichandraNadagouda
This document discusses pharmaceutical packaging and different types of packaging materials used. It begins by defining packaging and outlining its key functions of protection, preservation, presentation, and promotion. It then discusses ideal qualities for pharmaceutical packaging and types of packaging including primary, secondary, and tertiary packaging. The document focuses on primary packaging materials and medical device packaging, outlining different package types used and characteristics of materials like Tyvek, films, foils, and thermoformable plastics.
The document provides an overview of a 2-day technical seminar on vendor validation presented by APPON Quality Circle. It discusses key topics covered in the seminar including why vendor validation is important, areas that require validation, methods of validation, requirements, vendor monitoring, evaluation, and disqualification. Vendor validation helps ensure consistent quality of materials and compliance with regulations to reduce risks and costs. A risk-based approach is recommended to qualify and monitor vendors based on performance metrics and compliance.
Line clearance is an important procedure to prevent mix-ups and mistakes during manufacturing. It involves three stages: clearing, cleaning, and checking. During clearing, materials from the previous production are removed. Next, cleaning is done according to standard operating procedures. Finally, the line is checked and any issues are recorded before clearance is given to begin the next production. Line clearance must be performed before various stages of production such as dispensing, filling, packaging, and more. It helps ensure safety and quality in manufacturing.
This presentation is compiled by “ Drug Regulations” from freely available resources like the FDA on the World wide web.
“Drug Regulations” is a non profit organization which provides free online resource to the Pharmaceutical Professional.
Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals.
The document shows how to convert between different duration formats. It provides examples of converting decimal hours (0.8 h, 2.5 h, etc.) to hours and minutes. For each example, it performs the conversion by separating the decimal into hours and fractional hours, then converting the fractional hours to minutes. So for example, 0.8 h is converted to 0 h 48 min by treating 0.8 as 8/10 hours and calculating 8/10 * 60 min.
This is a booklet of eco-company, which contains the description of natural sweets, history and experience of company-manufacturer and compellation to the client.
The document provides information about auditing a microbiological laboratory. It defines quality audits and outlines the scope and objectives of auditing. Key areas that are audited include laboratory equipment, standard operating procedures, documentation, environmental monitoring, and testing processes. The document discusses auditing the laboratory facility, equipment, documentation systems, and testing methods to ensure compliance with standards.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
The two most commonly used within microbiology are
HACCP (which originated in the food industry) and FMEA
(developed for engineering). This article explores these two
approaches, first with a description of HACCP, followed by a
description and case study of FMEA in sterility testing.
This document discusses key considerations for the aseptic manufacturing of sterile pharmaceutical products. It covers classification of clean areas, environmental monitoring, preparation and filtration of solutions, personnel requirements, equipment sterilization, and validation of aseptic processes. The main objectives are to prevent microbial contamination and maintain sterility throughout manufacturing.
Good Manufacturing PracticeFor LVP,SVP, ophthalmic veterinary medicine, bulk chemicals & invitro diagnostic
For Good business Practice
A control process gives reproducibility & product consistency with in known limits
Provides license to do business.
Stability study of Pharmaceutical Products and Regulatory Requirements Md. Zakaria Faruki
A marketed product stability program fulfills registration
commitments and ensures that marketed product is
stable until expiry date stamped on product
label....
Stability studies should be planned on the
basis of pharmaceutical R&D and regulatory
requirements...
This document summarizes guidelines for stability testing of biotechnological and biological products. It discusses factors that can affect stability, including temperature, humidity, light and container materials. The guidelines specify conducting real-time stability studies at the proposed storage temperature and testing potency, purity and degradation over time. Manufacturers must propose a stability-indicating profile and validate methods to detect any changes to the identity, purity or potency of the product.
Self-inspection and quality audits are important parts of a quality management system to ensure ongoing compliance with good manufacturing practices (GMP). Self-inspections evaluate all aspects of production and quality control to detect any noncompliance and recommend corrective actions. The self-inspection team should consist of objective personnel not from the departments being inspected. The inspection covers facilities, equipment, documentation, hygiene, and other GMP requirements. Quality audits supplement self-inspections by examining the entire quality system. Supplier audits also help ensure materials meet specifications. GMP inspectors evaluate a company's self-inspection program through reviewing records and policies to check that inspections are properly conducted and documented.
This document provides an overview of cleaning validation. It defines cleaning validation as removing contaminants from equipment to safely reuse. It discusses cleaning mechanisms like solubility and wetting. Common cleaning agents include water, surfactants, solvents, acids, bases and oxidants. Automated cleaning methods are fixed CIP while manual includes soaking, brushing and wiping. Key cleaning parameters are time, temperature, chemistry and flow. The document also covers grouping strategies to select representative items for validation and considering worst cases.
The document outlines procedures for investigating out-of-specification or atypical laboratory test results. It describes conducting a Phase I investigation by the analyst and supervisor to identify obvious errors, and a Phase II investigation when no error is found. Phase II may involve hypothesis testing, retesting using the original sample if possible, or obtaining a new sample. If no assignable cause is identified after manufacturing and laboratory investigations, retesting a portion of the original sample may be considered with approval of a documented test plan.
Change control is a formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might effect a validated status. The intent is to determine the need for the action that would ensure that the system is maintained in a validated state.
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
These are the tests performed between QA and QC and provides for the authorization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC such as physical, chemical, microbiologic and biologic tests.
The document summarizes ICH guidelines for stability studies of new drug substances and products. It discusses the objectives and scope of stability testing, including providing evidence of a drug's quality over time under various environmental conditions to establish storage requirements and shelf life. The types of stability testing include chemical, physical, microbiological, therapeutic, and toxicological. Testing is conducted over various time periods and storage conditions as outlined in the ICH Q1A-Q1F guidelines. Evaluation of stability data includes assessing parameter results and using statistical analyses to determine a product's retest period or shelf life.
paharmaceutical packaging Medical device Packaging types of medical device p...RavichandraNadagouda
This document discusses pharmaceutical packaging and different types of packaging materials used. It begins by defining packaging and outlining its key functions of protection, preservation, presentation, and promotion. It then discusses ideal qualities for pharmaceutical packaging and types of packaging including primary, secondary, and tertiary packaging. The document focuses on primary packaging materials and medical device packaging, outlining different package types used and characteristics of materials like Tyvek, films, foils, and thermoformable plastics.
The document provides an overview of a 2-day technical seminar on vendor validation presented by APPON Quality Circle. It discusses key topics covered in the seminar including why vendor validation is important, areas that require validation, methods of validation, requirements, vendor monitoring, evaluation, and disqualification. Vendor validation helps ensure consistent quality of materials and compliance with regulations to reduce risks and costs. A risk-based approach is recommended to qualify and monitor vendors based on performance metrics and compliance.
Line clearance is an important procedure to prevent mix-ups and mistakes during manufacturing. It involves three stages: clearing, cleaning, and checking. During clearing, materials from the previous production are removed. Next, cleaning is done according to standard operating procedures. Finally, the line is checked and any issues are recorded before clearance is given to begin the next production. Line clearance must be performed before various stages of production such as dispensing, filling, packaging, and more. It helps ensure safety and quality in manufacturing.
This presentation is compiled by “ Drug Regulations” from freely available resources like the FDA on the World wide web.
“Drug Regulations” is a non profit organization which provides free online resource to the Pharmaceutical Professional.
Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals.
The document shows how to convert between different duration formats. It provides examples of converting decimal hours (0.8 h, 2.5 h, etc.) to hours and minutes. For each example, it performs the conversion by separating the decimal into hours and fractional hours, then converting the fractional hours to minutes. So for example, 0.8 h is converted to 0 h 48 min by treating 0.8 as 8/10 hours and calculating 8/10 * 60 min.
This is a booklet of eco-company, which contains the description of natural sweets, history and experience of company-manufacturer and compellation to the client.
La Unión Europea ha acordado un paquete de sanciones contra Rusia por su invasión de Ucrania. Las sanciones incluyen restricciones a las transacciones con bancos rusos clave y la prohibición de la venta de aviones y equipos a Rusia. Los líderes de la UE también acordaron excluir a varios bancos rusos del sistema SWIFT de mensajería financiera.
Pediatric and ophthalmic software programs help doctors and parents better manage patient care. The population growth has increased patient volumes, making manual record-keeping difficult and error-prone. Pediatric software tracks children's vaccination schedules to ensure timely immunizations. Ophthalmic software allows eye doctors to efficiently document patient visits and medical histories to avoid medication mix-ups. Both programs improve record accuracy and help providers deliver quality care.
El documento resume la historia de la cirugía desde sus orígenes hasta la actualidad. Comenzó con técnicas rudimentarias para tratar heridas y se fue desarrollando a lo largo de los siglos, con avances como la trepanación en el 3000 a.C., el conocimiento de la anatomía en Egipto y Grecia, y el surgimiento de la cirugía moderna con el descubrimiento de la anestesia y los métodos antisépticos y asépticos en los siglos XIX y XX. Hoy en día la cirugía es una especialidad mé
NESHCo-webinar_DKH-I-Am-New-Day-campaign_low-resLaura Dunn
The document summarizes a campaign led by Day Kimball Healthcare (DKH) to advocate against funding cuts proposed by the Connecticut state government that would have significantly reduced funding to DKH and jeopardized its operations and services. The campaign utilized grassroots efforts including a public pledge, legislative advocacy, earned media coverage, social media, and advertising to educate the community about DKH's value and rally support. Through thousands of community pledges and petitions, favorable media coverage, and sustained pressure, the campaign helped reduce the proposed cuts from $12 million to only $1.2 million, allowing DKH to avoid major cuts. Key factors in the campaign's success included taking a team approach, customizing messaging for DKH's situation,
Este documento presenta un resumen de tres oraciones de los siguientes temas:
1) Los sistemas de solución de conflictos como la autotutela, la autocomposición y la heterocomposición.
2) El concepto de debido proceso como un conjunto de actuaciones destinadas a alcanzar una finalidad predeterminada y como un derecho a ser oído con garantías.
3) Las funciones esenciales, estructura y principios del poder judicial así como el perfil, deberes y terminación de la carrera de los jueces.
El documento resume la historia de la anestesia desde la antigüedad hasta la actualidad. Comienza describiendo métodos primitivos de causar insensibilidad como la compresión de la carótida, y continúa detallando el desarrollo de anestésicos a través de los años, incluyendo el éter, cloroformo, óxido nitroso y propofol. También cubre hitos como el primer uso documentado de anestesia quirúrgica y el establecimiento de las sociedades de anestesiología.
Seminar Cradle to Cradle® Practical Applications in Area Development - 14:15 - 14:30 - Cradle to Cradle as Business approach – The view from the frontrunners - Stef Kranendijk (former CEO Desso)
Historia de la anestesia y los inicios en la República DominicanaJorge Amarante
Este documento resume la historia de la anestesia desde sus orígenes hasta avances recientes. Detalla descubrimientos clave como el óxido nitroso por Priestley en 1772, el éter por Crawford Williamson en 1846 y el cloroformo por James Simpson en 1847. También describe personajes importantes como Wells, Morton y Snow y cómo popularizaron la anestesia. Finalmente, resume avances modernos como monitoreo, anestésicos inhalatorios e hipnóticos endovenosos.
Este documento define y explica los diferentes tipos de textura musical, incluyendo textura monódica, homofónica, polifónica y de melodía acompañada. También describe las formas musicales más comunes como la forma estrófica, binaria, ternaria y rondó. Finalmente, detalla las partes comunes que componen la forma en la música popular urbana, como estrofas, estribillos, puentes e introducciones.
Alcohol & Medication in Pregnancy Conference AgendaHannah Stockdale
This document outlines the agenda for a two-day conference on alcohol consumption during pregnancy and its potential consequences. Day 1 focuses on enhancing understanding of substance use in pregnancy through presentations and workshops. Day 2 focuses on research methodologies through keynote speeches and updates on current studies. The conference aims to raise knowledge on how alcohol and medications during pregnancy can impact health, and explores qualitative and quantitative research approaches. It is aimed at medical, nursing, psychology and sociology students and professionals with an interest in maternal and child health.
This document summarizes the key aspects of Chrome extensions including:
- Chrome extensions are small programs that modify and enhance the Chrome browser functionality
- Extensions have a general structure including manifest.json, background pages, content scripts, and CSS/HTML/JS files
- Content scripts run in the context of web pages and have limited access to the Chrome API and web page resources
- Extensions use message passing to communicate between the background page and content scripts
The Parenteral Drug Association Italy Chapter is hosting a one-day conference on September 10, 2015 in Florence, Italy to discuss highlights from recent PDA conferences on parenteral packaging and aseptic manufacturing. The conference will provide updates on regulations, technologies, and applications used in sterile products, including discussions on particles, container closure integrity, and environmental monitoring. Speakers from pharmaceutical companies and technology vendors will present case studies and the latest innovations in automated inspection systems.
The Parenteral Drug Association Italy Chapter is hosting a one-day conference on September 10, 2015 in Florence, Italy to discuss highlights from recent PDA conferences on parenteral packaging and aseptic manufacturing. The conference will provide updates on regulations and technologies related to sterile products manufacturing. Speakers from pharmaceutical companies and vendors will present case studies on ensuring container closure integrity and achieving quality standards in parenteral products manufacturing through automation and environmental monitoring.
The Parenteral Drug Association Italy Chapter is hosting a one-day conference on September 10, 2015 to discuss highlights from recent PDA conferences on parenteral packaging and aseptic manufacturing. The forum will provide updates on regulations and technologies related to sterile products production, including container closure integrity and environmental monitoring. Speakers from pharmaceutical companies and vendors will present case studies and the latest technology solutions to help companies improve quality standards and compliance.
Blue Stain® uses a specialized cytopathology stain and advanced image analysis software to rapidly diagnose oral, gynecological, and anal cancers. Samples taken during medical appointments are digitized and analyzed by certified pathologists within 30 minutes, providing fast results compared to traditional methods. The technology aims to reduce cancer mortality rates by enabling earlier detection and treatment. Blue Stain® is seeking funding to expand pilot programs and certification efforts to introduce the product into large medical practices and cancer screening programs.
A guide to brazil toiletry perfume and cosmetic products compliance requirementsInmetro
This document provides a guide to the compliance requirements for toiletry, perfume, and cosmetic products in Brazil. It outlines the key regulatory authorities - the Brazilian Health Regulatory Agency (Anvisa) and the National Institute of Metrology, Quality and Technology (Inmetro). It also summarizes Anvisa's product market authorization process, which involves either registration or prior notification for products exempted from registration. The guide provides an overview of relevant regulations, standards, testing laboratories, and other stakeholders in the compliance process for these types of products in Brazil.
Sonia Martín has over 15 years of experience in clinical trials and pharmaceutical administration. She currently works for Novonordisk providing administrative support for clinical trials, including managing files, supplies, meetings, and payments. Previously she worked for Janssen Cilag and Roche Farma in roles focused on ethics committee submissions and management, contracts, and database maintenance. She has a Bachelor's Degree in Psychology and a Master's Degree in Clinical Trial Monitoring and Medical Affairs.
This document discusses the results of focus groups conducted for the Food Safety Market project. The focus groups provided feedback on business scenarios and user stories for various actors in the food supply chain, including retailers, food processors, certification bodies, and food safety authorities. Main concerns raised included convincing suppliers to participate, ensuring data security and privacy, and understanding costs. The focus groups found value in solutions that facilitate data sharing and help select the best certification options.
Ebers and biogaran innovation challengeFacundo Noya
Ebers is a startup specialized in diabetic foot care and prevention. Our principal solution are smart insole that combines pressure, temperature and humidity measure with algorithm to alert early for any risk to diabetic patients.
FAsTEST has devised a new method for analysis of fatty acids (including Omega3), which allows reducing the time and cost compared to other Fatty Acid analysis.
The document summarizes the services and research activities of Abich srl, a contract research organization that provides testing and analysis services for cosmetic, biomedical, and consumer product companies. Specifically, Abich focuses on in vivo and in vitro testing of cosmetics, developing alternative testing methods that do not use animals, and regulatory consulting. Abich has laboratories in Italy, Canada, and Milan and collaborates with hospitals on developing new testing methods. The CEO discusses Abich's role in the Smartnano project to develop techniques for detecting nanoparticles and their applications in analyzing consumer products like sunscreens.
This document announces a conference on evolving guidelines for disclosing healthcare professional spending across Europe. The 6th Annual Global Transparency Reporting Congress will be held on April 7-8, 2016 in Frankfurt, Germany and will feature presentations from transparency reporting professionals from various pharmaceutical companies and industry associations. The conference will provide insights on implementing disclosure guidelines and managing compliance risks related to healthcare professional payments.
IDMP Implementation - Impact on Data, Systems and Processes. How to cover gap...Torben Haagh
ISO IDMP will be mandatory from July 1st 2016 and it will make a fundamental impact on the way the pharmaceutical industry is required to collect, manage and submit relevant data. Now is the last call for all marketing authorisation holders to (re)think their data submission policies and processes to make sure you close your IDMP implementation gaps in the next 12 month and have a clear vision of the next challenges lying ahead!
Don’t miss out on the opportunity to get your questions answered, to benchmark the stage of your preparation, to initiate partnerships and to take an active part in designing the RIM’s community future agenda! Join us this summer in Berlin and gain valuable, practical information:
# Learn how to assess and analyse data requirements for the IDMP standards by discussing possible interpretations with our expert from regulatory bodies on-site!
# Benchmark your own IDPM Implementation process with peers from both big and mid-size pharma
# Share insights how the IDMP standards are changing the interactions between IT-Systems, company departments, contract manufacturers and regulatory agencies
# Discuss and compare with your peers experiences with vendors and solution providers offering help to achieve your IDMP implementation goals!
For more information visit our website: http://bit.ly/EventWebsite
If you would like to be part of the conference, you can register now here: http://bit.ly/Register-Event
why FDA at my Facility is, and what do I do During an InspectionGlobalCompliancePanel
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
Presentation on the importance of commercialisation, the VITALISE Innovation and Commercialisation Monitoring System, the EU Innovation Radar Platform, the KTH Innovation Readiness Model, and the case study of HearArt Technologies in the commercialisation process.
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
This document provides information about the "Pharma Compliance Europe" conference taking place on October 7-8, 2015 in London. The conference will bring together senior compliance executives from pharmaceutical companies to discuss challenges in compliance, transparency, and managing relationships with healthcare professionals. It will include keynote speeches, panels, roundtable discussions, and an exhibition on topics such as developing global compliance programs, data privacy laws, monitoring practices, and culture of integrity. The event aims to help compliance professionals benchmark their strategies and programs against industry best practices.
Pharma Maintenance2Reliability minds 2013 - MAIN PRMaria Willamowius
One of Europe´s most important conferences for strategic approaches and challenges in the field of plant asset- maintenance and reliability management in the Pharma & Life Science industries More information regarding speakers, keynotes, main topics and program on : http://pharma-maintenance2013.we-conect.com/
medical disposables -gloves,nonwovens,plastic disposables and sterilization p...倩倩 郭
There are disposable gloves,nonwoven disposables,plastic disposables and sterilization pouches in intco medical.
Contact:Lynette Guo
Email:lynetteguo@intco,com,cn
Phone:+86-34978818-1118
"Food recall is the cornerstone of a robust food recall program in any food industry. It encompasses meticulous monitoring, swift communication, and decisive action. By identifying potential risks early, companies can prevent widespread consumer harm and safeguard their reputation.
The hold and release program for non-conforming products in the food industry is crucial for ensuring product safety and regulatory compliance. By temporarily halting distribution until thorough evaluation and resolution, it safeguards consumers from potential harm. This process upholds quality standards, preserves brand reputation, and fosters trust among customers.
Unlock the latest insights in food factory engineering and design with 'Tech-Knowledge' – your guide to cutting-edge solutions and industry expertise in F&B industry."
Similar to Container Closure Integrity & Visual Inspection Regulations (20)
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
Gender and Mental Health - Counselling and Family Therapy Applications and In...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) CurriculumMJDuyan
(𝐓𝐋𝐄 𝟏𝟎𝟎) (𝐋𝐞𝐬𝐬𝐨𝐧 𝟏)-𝐏𝐫𝐞𝐥𝐢𝐦𝐬
𝐃𝐢𝐬𝐜𝐮𝐬𝐬 𝐭𝐡𝐞 𝐄𝐏𝐏 𝐂𝐮𝐫𝐫𝐢𝐜𝐮𝐥𝐮𝐦 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞𝐬:
- Understand the goals and objectives of the Edukasyong Pantahanan at Pangkabuhayan (EPP) curriculum, recognizing its importance in fostering practical life skills and values among students. Students will also be able to identify the key components and subjects covered, such as agriculture, home economics, industrial arts, and information and communication technology.
𝐄𝐱𝐩𝐥𝐚𝐢𝐧 𝐭𝐡𝐞 𝐍𝐚𝐭𝐮𝐫𝐞 𝐚𝐧𝐝 𝐒𝐜𝐨𝐩𝐞 𝐨𝐟 𝐚𝐧 𝐄𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫:
-Define entrepreneurship, distinguishing it from general business activities by emphasizing its focus on innovation, risk-taking, and value creation. Students will describe the characteristics and traits of successful entrepreneurs, including their roles and responsibilities, and discuss the broader economic and social impacts of entrepreneurial activities on both local and global scales.
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Temple of Asclepius in Thrace. Excavation resultsKrassimira Luka
The temple and the sanctuary around were dedicated to Asklepios Zmidrenus. This name has been known since 1875 when an inscription dedicated to him was discovered in Rome. The inscription is dated in 227 AD and was left by soldiers originating from the city of Philippopolis (modern Plovdiv).
1. KEY POINTS
The following key points are discussed:
• Container-closure integrity is a critical property of a pharmaceutical product. This attribute is especially
important for sterile products. The US Food and Drug Administration guidance has categorized container-
closure risks for common pharmaceutical products including degree of concern associated with route of
administration (highest-low) and likelihood of packaging component-dosage form interaction (high-low).
Sterile product container closure systems are described for most common sterile products including
ampoules, sterile vials, and other systems. Multiple integrity test methods including microbial immersion
test, microbial aerosol challenge, bubble test, and other methods are described.
Validation considerations for integrity tests are discussed.
INTRODUCTION
One of the main purposes of a container closure system is to protect its contents from the surrounding
environment. In the case of sterile products, this means maintaining the sterility of the product. The
container-closure system may also need to protect the product from other potentially harmful agents such
as light, moisture, and oxygen. This paper discusses container-closure integrity—maintaining the sterility of
the product plus protecting the product from moisture and oxygen. It further discusses various test
methods used to test for container-closure integrity.
The US Food and Drug Administration defines a container-closure system as the following:
“A container closure system refers to the sum of packaging components that together contain and protect
the dosage form. This includes primary packaging components and secondary packaging components, if
the latter are intended to provide additional protection to the drug product. A packaging system is equivalent
to a container closure system”
Presented by:
Andrea Simonetti
Director of Pharma
Bonfiglioli Engineeringa
a TASI GROUP Company
Manage the global pharmaceutical initiative at TASI APTI group. Design and
implement business initiatives and strategic development activities by leading and
overseeing the activities of an international team. Create synergies with other
companies and industry associations and foster positive business relationships
with clients by supporting multilateral cooperation and generating added value. In
2010 started providing educational support to US Food and Drug Administration -
Office of Pharmaceutical Science. Currently working with PDA “Technical Report
27 – Pharmaceutical Package Integrity” and Prefilled Syringes task force teams
Prepared by:
Gaetano Fiorentino
President PDA Italy
Many years of experience in the management of facilities and production of
Parenterals. Great knowledge of vision systems management software and
monitoring SCADA Expert in all process validation and new plant and
machinery.Development and realization of machines prototypes in order to
improve the quality and productivity. Continuous improvement of quality and
economic production in the crops in being and existing plants. Management
documentation and staff training. Continuously updated on new technologies and
the feasibility study on the potential for their use in the pharmaceutical
environment.
.
Container Closure Integrity & Visual Inspection
Regulations, Theory, Test Methods and Applications of
CCI Innovations including Hands-On Activities
2015 PDA Italy Conference, Workshop
10 December,| Vigarano Pieve, Italy
Via Rondona, 33 44049 Ferrara
2. AGENDA
09:00. Welcome and Introduction
a) Presentation of participants
b) Scope of the training
c) Agenda for the day
10:00 Technology Overview: Non Destructive Test and Inspection Methods for Parenteral
Containers
a) CCIT: Vacuum Decay, Pressure Decay, Lid Deflection, Force Decay
b) Visual Inspection: Detection of Critical, major and minor defects
c) Headspace Gas Analysis: Monitoring Oxygen + Moisture Level & Absolute Pressure in the
headspace of sterile parenteral containers
11:00 Regulatory Requirements and Pharmacopeial Updates
a) EU, US, Other Countries
12:00. Technology Detail: Each Test and Inspection Method is Detailed
a) Principle of operation
b) Industry case studies
c) Challenge tests
d) Validation approach
e) Lessons learned
13:00 Lunch Break
14:00. Hands-On:
1. Laboratory:
a) How to set-up and run off-line test and inspection systems
b) Creation of positive controls and reference standards
c) Testing and process validation
d) Practical live demonstration
15:30 Lunch Break
16:00. Hands-On:
2. Production Area:
a) Analysis of a 100% in-line Headspace Gas Analysis equipment
Container Closure Integrity & Visual Inspection
Regulations, Theory, Test Methods and Applications of
CCI Innovations including Hands-On Activities
3. 2015 PDA Italy Conference, Workshop
2 WAYS
TO REGISTER
Container Closure Integrity & Visual Inspection
Your Contact Person is
Gaetano Fiorentino at PDA Italy
dt-fiorentino@italfarmaco.com
Elena Baccalaro at CCI Italy
elena.baccalaro@congressiefiere.com
10 December | Ferrara | Italy
1 ONLINE: https://www.pda-it.org/TR65
2
4
1 ONLINE: https://www.pda-it.org/CCI
EMAIL: elena.baccalaro@congressiefiere.com
EMAIL: dt-fiorentino@italfarmaco.com
ThisPDF-fileprovidesanautomatic
fill-in function. Your signature,
however, is needed in writing.
1Your Contact Information
Ifthisformisanupdatetoapreviouslysubmittedform,pleasecheckhere.
Mr. Ms. Dr. Nonmember
IwanttobecomeaPDAMember.
Please sendme asubscriptionform
Name(Last, First, MI)*
PDA Member IDNumber
Job Title*
Company* Department
Mailing Address
City Postal Code
Country Email *
Business Phone Fax
Substituting for
(Check only if you are substituting for a previously enrolled colleague; a nonmember substituting for member must pay the membership fee.)
Registration
No PDA membership included 3 Payment
All fees given in Euro andexcluding VAT
Conference (10December)
PDA Member
Nonmember 395
By Bank Transfer beneficiary: PDAItaly Chapter
IBAN: IT55T0103071940000002767926
BIC: PASCITMMPOG
Bank Address: BancaMontedeiPaschidiSiena,AgenziadiPoggibonsi,Loc.Salceto,95–53036
Poggibonsi(SI)
The fee includes course documentation as well as mid-session refreshments and lunch.
Excellent networking opportunities with snacks and drinks will be given. The fee does not
include the hotel accommodation. PDA Italy has secured a limited number of rooms at a
special group rate.
Group Registration Discount Register 5 colleagues for the con-
ference at the same time and receive the 5th registration free. For
more information on group discounts please contact Gaetano
Fiorentino at dt-fiorentino@italfarmaco.com Other discounts cannot
be applied.
DiscountforExhibitingCompanies Pleasemarkhereifyourcompanyisanexhibitortothiseventand
you will receive the conference ticket at the special price of 800 Euro per ticket. No further discounts are
applicablewiththisoption(asPDAMembershipDiscountorGroupTicketdiscount).Thisspecialratedoesnot
include one-year PDA membership. Date Mandatory Signature
CONFIRMATION: Transmitting your filled-in registration form constitutes a binding application for the specific event. PDA Europe will send you a confirmation including payment details. A legally binding contract is concluded
once PDA Europe has sent a written invoice by mail to you. You must have a written confirmation (including invoice) to be considered enrolled in a PDA event. Please allow one week for receipt of confirmation letter. Payment
must be received orguaranteed byPurchase Order or credit card details on 1st dayofevent, atthe very latest. SUBSTITUTIONS: Ifyou areunable to attend, substitutions arewelcome and can be made atanytime, including onsite
at the prevailing rate. If you are registering as a substitute attendee, please indicate this on the registration form. Changes are free of charge until prior to the start of the event. REFUNDS: Refund requests must be sent to PDA
ITALY. If your written request is received on or before 16 October 2015, you will receive a full refund minus a 150 € excl. VAT handling fee. After that time, no refund or credit requests will be approved. If you are an unpaid
registrant and do not attend the event, you are responsible for paying the registration fee. On-site registrants are not guaranteed to receive conference materials until alladvanced registered attendees receivethem.PDAItaly
worksPCI-Compliant.EVENTCANCELLATION:PDAreservestherighttomodifythematerialorspeakers/instructorswithoutnotice,ortocancelanevent. Ifanevent must be canceled, registrants will be notified byPDAassoon as
possible andwill receive afull refund. PDAwill not be responsible for airfare penalties or othercosts incurred duetocancellation. For more details,contact PDAatinfo-Italy@pda.org DOCUMENTATION: With your signature you
give complete picture usage right toPDAand allow to film your exhibition space and intervention inthe event, including the recording ofyour presentationfor videopurposes (withyourslides,voice andimage).This rightextends
alsototheuseoftheresultingimagesinfilmdocumentationforwebinarsandsimilaritemsproducedbyPDA.
www.pda-it.org/CCI
2
4 Location
Headquarters
Bonfiglioli Engineering
via Rondona, 33
44049 - Vigarano Pieve (FE)
Italy
+39 0532 715 631
+39 0532 715 625
Servizio di navetta da e per la stazione di
Bologna
4. Container Closure Integrity & Visual Inspection
10 December - Ferrara
MAKING IT EASIER FOR BOTH OF US
Ifuncertain aboutyour member IDnumberand/oryourmembershipstatus,call or @Mr. Gaetano Fiorentino.
+39 02 6443-3435 dt-fiorentino@italfarmaco.com
Pleasewaituntilwesendourinvoicetoyou.
It is helpful to reference our invoice numberin your bank transfer details.
Pleasenotetheregistrationandcancellationpoliciesatthebottomoftheform.
RegistrationcannotbecompletedbysendingPurchaseOrderalone.APurchaseOrderisonlyacceptedifa
complete registration form is enclosed or follows very soon.
This is particularly important if billing address and site address are different. Contact your accounting depart-
ment for correct address and company name. There could be special requirements for accounting. Changesin
the billing address (if induced by participating company) will be charged-prior to the startoftheevent.
Bank transfers are confirmed upon receipt of full payment.
Refunds to bank accounts can be done if payment had been done by bank transfer and the following details
areprovided: a) Name of your bank b) IBAN number c) Swift/BIC code
Ifaparticipantisunable to attend,substitutionsarewelcomeatanytime.Changesarefreeofchargeuntil
priortothestartoftheevent.
Tel: +39 02 6443-3435 Email: dt-fiorentino@italfarmaco.com
Tel: +39 011 2 4 4 6 9 1 5 Email: Elena.baccalaro@centrocongressiefiere.com
T HAN K YO U FOR YOUR COOPERATION!
10 For assistance contact: Elena Baccalaro Executive Manager Centro Congressi Internazionale Italy
9 For assistance contact: Gaetano Fiorentino, President PDA Italy
8 Substitutions
7 Refund/Credit Notes
6 Confirmation of your registration
5 Please state the correct billing address on the registration form
4 Purchase Orders
3 Complete and sign the event registration form
2 Do not send money in advance
1 Please include your member ID number on registration form if available/known
www.pda-it.org/CCI